A compound, use thereof, pharmaceutical composition, and method for treating and / or preventing nuclear receptor mediated conditions and for treating and / or preventing type i diabetes, type ii diabetes, impaired glucose tolerance, resistance to insulin or obesity

摘要

"COMPOSITION, USE OF THE SAME, PHARMACEUTICAL COMPOSITION, AND METHODS FOR THE TREATMENT AND / OR PREVENTION MEDIATED BY NUCLEAR RECEPTORS AND FOR THE TREATMENT AND / OR PREVENTION OF THE TYPE AND DIABETIC DIABETIC TYPE II, DIABETIC TYPE II, DIABETIC TIA, II INSULIN RESISTANCE OR OBESITY "New compounds of the general formula (1), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and treatment methods using these compounds and compositions. The present compounds may be useful in the treatment and / or prevention of Peroxisome Proliferator Activated Receptor (PPAR) -mediated conditions, in particular the PPAR sym subtype.